239 related articles for article (PubMed ID: 19711289)
1. [Diagnosis and therapy of advanced breast carcinoma: summary of the NICE guidelines].
Murray N; Winstanley J; Bennett A; Francis K
Praxis (Bern 1994); 2009 Aug; 98(17):961-4. PubMed ID: 19711289
[No Abstract] [Full Text] [Related]
2. Locally recurrent or metastatic breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.
Cardoso F; Harbeck N; Fallowfield L; Kyriakides S; Senkus E;
Ann Oncol; 2012 Oct; 23 Suppl 7():vii11-9. PubMed ID: 22997442
[No Abstract] [Full Text] [Related]
3. Synchronous metastatic breast cancer in a husband and wife.
Kerin MJ; O'Hanlon DM; Given HF
Ir J Med Sci; 1996; 165(1):50. PubMed ID: 8867501
[TBL] [Abstract][Full Text] [Related]
4. A solitary bone lesion in a patient with previous breast cancer and the importance of bone biopsy: a case report and a review of guidelines.
Schiavon G; Tait DM; Briggs TW; Smith IE
Clin Breast Cancer; 2013 Feb; 13(1):77-80. PubMed ID: 23199805
[No Abstract] [Full Text] [Related]
5. Uveal metastases from breast carcinoma in three male patients.
Lam A; Shields CL; Shields JA
Ophthalmic Surg Lasers Imaging; 2006; 37(4):320-3. PubMed ID: 16898395
[TBL] [Abstract][Full Text] [Related]
6. Primary and secondary distant metastatic breast cancer: two sides of the same coin.
Güth U; Magaton I; Huang DJ; Fisher R; Schötzau A; Vetter M
Breast; 2014 Feb; 23(1):26-32. PubMed ID: 24215983
[TBL] [Abstract][Full Text] [Related]
7. Chinese female breast cancer patients show a better overall survival than their male counterparts.
Xia LP; Zhou FF; Guo GF; Wang F; Wang X; Yuan ZY; Zhang B
Chin Med J (Engl); 2010 Sep; 123(17):2347-52. PubMed ID: 21034547
[TBL] [Abstract][Full Text] [Related]
8. Regression of choroidal metastasis from a carcinoma of the male breast: case report.
Paoli D
Ophthalmologica; 1998; 212 Suppl 1():74-6. PubMed ID: 9730758
[TBL] [Abstract][Full Text] [Related]
9. Invasive papillary carcinoma of the breast: an overview of twenty-four cases.
Vural O; Alnak A; Altundag K
Am Surg; 2012 Mar; 78(3):E144-5. PubMed ID: 22524741
[No Abstract] [Full Text] [Related]
10. [Selection of therapeutic procedures according to the clinicopathological features of breast cancer].
Izuo M; Yokoe T
Gan To Kagaku Ryoho; 1986 Jan; 13(1):37-45. PubMed ID: 2935084
[TBL] [Abstract][Full Text] [Related]
11. A young woman with a small ER-positive breast cancer, a micrometastatic axillary lymph node, and an intermediate oncotype DX recurrence score.
Bowles DW; Rabinovitch R; Borges V; Urquhart A; Singh M; Finlayson C; Elias A
Oncology (Williston Park); 2007 Sep; 21(10):1212-7. PubMed ID: 17926799
[No Abstract] [Full Text] [Related]
12. Male breast cancer: a survey at the Helsinki University Central Hospital during 1981-2006.
Liukkonen S; Saarto T; Mäenpää H; Sjöström-Mattson J
Acta Oncol; 2010 Apr; 49(3):322-7. PubMed ID: 20397767
[TBL] [Abstract][Full Text] [Related]
13. [Treatment guideline for advanced or recurrent breast cancer].
Watanabe T; Katsumata N; Saijo N
Nihon Rinsho; 2000 Apr; 58 Suppl():237-45. PubMed ID: 11026001
[No Abstract] [Full Text] [Related]
14. Impact of the 21-gene recurrence score assay compared with standard clinicopathologic guidelines in adjuvant therapy selection for node-negative, estrogen receptor-positive breast cancer.
Partin JF; Mamounas EP
Ann Surg Oncol; 2011 Nov; 18(12):3399-406. PubMed ID: 21537874
[TBL] [Abstract][Full Text] [Related]
15. Intracystic papillary carcinoma of the breast: An in situ or invasive tumor? Results of immunohistochemical analysis and clinical follow-up.
Wynveen CA; Nehhozina T; Akram M; Hassan M; Norton L; Van Zee KJ; Brogi E
Am J Surg Pathol; 2011 Jan; 35(1):1-14. PubMed ID: 21084964
[TBL] [Abstract][Full Text] [Related]
16. [Prevalence of elevated serum CA 15-3 at time of metastatic relapse of breast cancer and correlation with hormone receptor status].
Bensouda Y; André F; Boulet T; Al-Ghuzlan A; Conforti R; Troalen F; Bourgier C; Errihani H; Spielmann M; Delaloge S
Bull Cancer; 2009 Oct; 96(10):923-8. PubMed ID: 19696005
[TBL] [Abstract][Full Text] [Related]
17. [New after-care guidelines in breast carcinoma].
Sauer H
Geburtshilfe Frauenheilkd; 1996 Sep; 56(9):M141-3. PubMed ID: 8991837
[No Abstract] [Full Text] [Related]
18. ER, HER2, and TOP2A expression in primary tumor, synchronous axillary nodes, and asynchronous metastases in breast cancer.
Jensen JD; Knoop A; Ewertz M; Laenkholm AV
Breast Cancer Res Treat; 2012 Apr; 132(2):511-21. PubMed ID: 21667123
[TBL] [Abstract][Full Text] [Related]
19. Correlation of clinical, pathological status, hormone receptor and C-erbB-2 oncoprotein in breast cancer patients.
Aryandono T; Harijadi ; Ghozali A
Gan To Kagaku Ryoho; 2000 May; 27 Suppl 2():600-6. PubMed ID: 10895217
[TBL] [Abstract][Full Text] [Related]
20. Tumor characteristics and recurrence patterns in triple negative breast cancer: a comparison between younger (<65) and elderly (≥65) patients.
Königsberg R; Pfeiler G; Klement T; Hammerschmid N; Brunner A; Zeillinger R; Singer C; Dittrich C
Eur J Cancer; 2012 Nov; 48(16):2962-8. PubMed ID: 22647688
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
